BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 20838963)

  • 1. Some Trends in Chem(o)informatics.
    Warr WA
    Methods Mol Biol; 2011; 672():1-37. PubMed ID: 20838963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoinformatics and library design.
    Zhou JZ
    Methods Mol Biol; 2011; 685():27-52. PubMed ID: 20981517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Interweaving of Cheminformatics and HTS.
    Kümmel A; Parker CN
    Methods Mol Biol; 2011; 672():435-57. PubMed ID: 20838979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applying data mining techniques to library design, lead generation and lead optimization.
    Weaver DC
    Curr Opin Chem Biol; 2004 Jun; 8(3):264-70. PubMed ID: 15183324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in cheminformatics methodologies and infrastructure to support the data mining of large, heterogeneous chemical datasets.
    Guha R; Gilbert K; Fox G; Pierce M; Wild D; Yuan H
    Curr Comput Aided Drug Des; 2010 Mar; 6(1):50-67. PubMed ID: 20370695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OSIRIS, an entirely in-house developed drug discovery informatics system.
    Sander T; Freyss J; von Korff M; Reich JR; Rufener C
    J Chem Inf Model; 2009 Feb; 49(2):232-46. PubMed ID: 19434825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoinformatics-applications in food chemistry.
    Martinez-Mayorga K; Medina-Franco JL
    Adv Food Nutr Res; 2009; 58():33-56. PubMed ID: 19878857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fragment informatics and computational fragment-based drug design: an overview and update.
    Sheng C; Zhang W
    Med Res Rev; 2013 May; 33(3):554-98. PubMed ID: 22430881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoinformatics in France.
    Varnek A
    Mol Inform; 2017 Oct; 36(10):. PubMed ID: 28994245
    [No Abstract]   [Full Text] [Related]  

  • 11. Informatics and modeling challenges in fragment-based drug discovery.
    Hubbard RE; Chen I; Davis B
    Curr Opin Drug Discov Devel; 2007 May; 10(3):289-97. PubMed ID: 17554855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Web-based cheminformatics and molecular property prediction tools supporting drug design and development at Novartis.
    Ertl P; Mühlbacher J; Rohde B; Selzer P
    SAR QSAR Environ Res; 2003; 14(5-6):321-8. PubMed ID: 14758976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational chemistry and cheminformatics: an essay on the future.
    Glen RC
    J Comput Aided Mol Des; 2012 Jan; 26(1):47-9. PubMed ID: 22160586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ChemModLab: a web-based cheminformatics modeling laboratory.
    Hughes-Oliver JM; Brooks AD; Welch WJ; Khaledi MG; Hawkins D; Young SS; Patil K; Howell GW; Ng RT; Chu MT
    In Silico Biol; 2011-2012; 11(1-2):61-81. PubMed ID: 22475752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural analysis of carboline derivatives as inhibitors of MAPKAP K2 using 3D QSAR and docking studies.
    Nayana RS; Bommisetty SK; Singh K; Bairy SK; Nunna S; Pramod A; Muttineni R
    J Chem Inf Model; 2009 Jan; 49(1):53-67. PubMed ID: 19119997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing the use of open-source software applications in drug discovery.
    Geldenhuys WJ; Gaasch KE; Watson M; Allen DD; Van der Schyf CJ
    Drug Discov Today; 2006 Feb; 11(3-4):127-32. PubMed ID: 16533710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular similarity: a key technique in molecular informatics.
    Bender A; Glen RC
    Org Biomol Chem; 2004 Nov; 2(22):3204-18. PubMed ID: 15534697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De novo drug design: integration of structure-based and ligand-based methods.
    Dean PM; Lloyd DG; Todorov NP
    Curr Opin Drug Discov Devel; 2004 May; 7(3):347-53. PubMed ID: 15216939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using Cheminformatics in Drug Discovery.
    Lawless MS; Waldman M; Fraczkiewicz R; Clark RD
    Handb Exp Pharmacol; 2016; 232():139-68. PubMed ID: 26318607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fragment-based quantitative structure-activity relationship (FB-QSAR) for fragment-based drug design.
    Du QS; Huang RB; Wei YT; Pang ZW; Du LQ; Chou KC
    J Comput Chem; 2009 Jan; 30(2):295-304. PubMed ID: 18613071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.